MiMedx集团 MDXG 深 沪
已收盘 08-01 16:00:00 美东时间
7.16
-0.030
-0.42%
华盛通- 最 高7.265
- 今 开7.08
- 成交量 129.72万股
- 最 低 6.78
- 昨 收 7.19
- 总市值 10.60亿
- 52周最高 10.14
- 市盈率 静 25.16
- 换手率 0.88%
- 52周最低 5.47
- 委 比 90.18%
- 总股本 1.48亿
- 历史最高 18.25
- 量 比 1.07
- 振 幅 6.75%
- 历史最低 0.83
- 每 手 1
- 风险率 1.20%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多What to Expect from Ardelyx's Earnings
Ardelyx (NASDAQ:ARDX) is gearing up to announce its quarterly earnings on Monda...
今天 04:01
Cantor Fitzgerald Maintains Overweight on MiMedx Group, Raises Price Target to $12
Cantor Fitzgerald analyst Ross Osborn maintains MiMedx Group (NASDAQ:MDXG) with a Overweight and raises the price target from $11 to $12.
07-31 20:54
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers OSR Holdings (NASDAQ:OSRH) stock rose 21.4% to $1.05 during Wednesday'...
07-31 05:06
MiMedx Group And Vaporox Collaborate To Co-Promote And Co-Market Their Wound Care Offerings
MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") and Vaporox, Inc. ("Vaporox") today jointly announced a collaboration, whereby the companies will co-promote and co-market their wound care offerings. As part
07-30 20:04
MIMEDX Announces Strategic Collaboration with Vaporox, Inc.
MIMEDX and Vaporox have entered a collaboration to co-promote and co-market their wound care solutions. MIMEDX has invested in Vaporox and gained exclusivity rights. Vaporox's Vaporous Hyperoxia Therapy (VHT) device treats chronic wounds using ultrasonic mist and concentrated oxygen, receiving FDA clearance for nine wound types. Both companies aim to expand market presence and improve patient outcomes through this partnership.
07-30 12:00
SA analyst upgrades/downgrades: OXY, AMZN, MDXG, CHTR
A handful of companies on Wall Street have seen recent Seeking Alpha analyst activity, including upgrades and downgrades. Amazon (AMZN) has been downgraded despite attractive valuations due to mixed f...
07-30 00:57
MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30
MiMedx Group, Inc. (MDXG) announced that it will report its second-quarter 2025 financial results on July 30, 2025, after market close. A webcast and conference call to discuss the results will begin at 4:30 p.m. ET on the same day. U.S. investors can join via 877-407-6184, international investors via 201-389-0877, and the conference ID is 13754722. A replay will be available on the company's website for 30 days. MiMedx, a leader in wound care so...
07-16 12:00
Cantor Fitzgerald Reiterates Overweight on MiMedx Group, Maintains $11 Price Target
Cantor Fitzgerald analyst Ross Osborn reiterates MiMedx Group (NASDAQ:MDXG) with a Overweight and maintains $11 price target.
07-15 20:45
Why Trade Desk Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Shares of The Trade Desk, Inc. (NASDAQ:TTD) rose sharply in pre-market trading ...
07-15 19:24
